Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00383630 · ClinicalTrials.gov registry record · Phase 2
Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure
A Phase 2 study, sponsored by Columbia University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00383630 is a Phase 2 study that was terminated before completion, run by Columbia University. The registered enrollment target is 1 participants.
The verdict
NCT00383630, a Phase 2 study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
Heart failure is a condition in which the heart is unable to pump enough blood to the body's other organs. A heart transplant may be necessary for some individuals with end-stage heart failure. Left ventricular assist devices (LVADs) can assist the heart in pumping blood, and are commonly used until a donor heart becomes available. Bone marrow cells injected into the heart may improve heart function and may lead to earlier LVAD removal. The purpose of this study is to evaluate the safety and effectiveness of injected bone marrow cells in improving heart function in individuals with LVADs who are awaiting heart transplants.
Interventions
- BIOLOGICAL Intramyocardial injection of bone marrow mononuclear cells
- BIOLOGICAL Intramyocardial injection of CD34+ selected bone marrow mononuclear cells
- DEVICE LVAD alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00383630
The ClinicalTrials.gov registry entry for NCT00383630 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Intramyocardial injection of bone marrow mononuclear cells is the first listed.
NCT00383630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00383630 about?
NCT00383630 is a clinical study titled "Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure". Heart failure is a condition in which the heart is unable to pump enough blood to the body's other organs. A heart transplant may be necessary for some individuals with end-stage heart failure. Left ventricular assist devices (LVADs) can assist the heart in pumping blood, and are commonly used until...
What is the current status of trial NCT00383630?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2007-09. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00383630?
The interventions under investigation include: Intramyocardial injection of bone marrow mononuclear cells (BIOLOGICAL), Intramyocardial injection of CD34+ selected bone marrow mononuclear cells (BIOLOGICAL), LVAD alone (DEVICE).
Who is sponsoring clinical trial NCT00383630?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.